Hideki Ushirogochi
University of Tokushima
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hideki Ushirogochi.
Antimicrobial Agents and Chemotherapy | 2004
William J. Weiss; Peter J. Petersen; Timothy M. Murphy; LuAnna Tardio; Youjun Yang; Patricia A. Bradford; Aranapakam Mudumbai Venkatesan; Takao Abe; Takeshi Isoda; Ado Mihira; Hideki Ushirogochi; Tsuyoshi Takasake; Steve Projan; John O'Connell; Tarek S. Mansour
ABSTRACT Novel penem molecules with heterocycle substitutions at the 6 position via a methylidene linkage were investigated for their activities and efficacy as β-lactamase inhibitors. The concentrations of these molecules that resulted in 50% inhibition of enzyme activity were 0.4 to 3.1 nM for the TEM-1 enzyme, 7.8 to 72 nM for Imi-1, 1.5 to 4.8 nM for AmpC, and 14 to 260 nM for a CcrA metalloenzyme. All the inhibitors were more stable than imipenem against hydrolysis by hog and human dehydropeptidases. Piperacillin was combined with a constant 4-μg/ml concentration of each inhibitor for MIC determinations. The combinations reduced piperacillin MICs by 2- to 32-fold for extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae strains. The MICs for piperacillin-resistant (MIC of piperacillin, >64 μg/ml) strains of Enterobacter spp., Citrobacter spp., and Serratia spp. were reduced to the level of susceptibility (MIC of piperacillin, ≤16 μg/ml) when the drug was combined with 4, 2, or 1 μg of these penem inhibitors/ml. Protection against acute lethal bacterial infections with class A and C β-lactamase- and ESBL-producing organisms in mice was also demonstrated with piperacillin plus inhibitor. Median effective doses were reduced by approximately two- to eightfold compared to those of piperacillin alone when the drug was combined with the various inhibitors at a 4:1 ratio. Pharmacokinetic analysis after intravenous administration of the various inhibitors showed mean residence times of 0.1 to 0.5 h, clearance rates of 15 to 81 ml/min/kg, and volumes of distribution between 0.4 and 2.5 liters/kg. The novel methylidene penem molecules inhibit both class A and class C enzymes and warrant further investigation for potential as therapeutic agents when used in combination with a β-lactam antibiotic.
Journal of Organometallic Chemistry | 2000
Yoshimitsu Nagao; Hiroaki Nishijima; Hitoshi Iimori; Hideki Ushirogochi; Shigeki Sano; Motoo Shiro
Abstract An attempt at an asymmetric Pummerer-type reaction of trans-4-benzyloxythiane-1-oxide (1) with 3-trifluoroacetyl-4S-isopropyl-1,3-thiazolidine-2-thione (2) resulted in failure but an attractive desulfurilative self-coupling reaction of 4S-isopropyl-1,3-thiazolidine-2-thione (6) occurred to give 4S-isopropyl-3-(4S-isopropyl-1,3-thiazolin-2-yl)-1,3-thiazolidine-2-thione (5). The same desulfurilative self-coupling reaction of compound 6 or 11 efficiently proceeded by treatment of diphenyl sulfoxide (7a) or methyl phenyl sulfoxide (7b) with 2 or 3-trifluoroacetyl-1,3-thiazolidine-2-thione (8) to afford each corresponding product 5 or 9. Eventually, we found a practically useful method for the synthesis of 5 and 9 by exploiting TiCl4 and sodium salt 12 or 13 of 1,3-thiazolidine-2-thiones. Interestingly, intramolecular non-bonded S⋯S interactions were recognized in the crystallographic structures of 5 and 9.
The Journal of Antibiotics | 2006
Takeshi Isoda; Hideki Ushirogochi; Koichi Satoh; Tsuyoshi Takasaki; Itsuki Yamamura; Chisato Sato; Ado Mihira; Takao Abe; Satoshi Tamai; Shigeki Yamamoto; Toshio Kumagai; Yoshimitsu Nagao
We discovered an orally active carbapenem, L-084, through pharmacokinetic studies on various prodrug esters of (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-1-carbapen-2-em-3-carboxylic acid (LJC11,036). L-084 showed a strong antimicrobial activity against Gram-positive and Gram-negative bacteria and exhibited the highest intestinal absorption among synthesized prodrugs of LJC11,036.
ChemMedChem | 2007
Tarek S. Mansour; Atul Agarwal; Aranapakam Mudumbai Venkatesan; Takao Abe; Ado Mihira; Tsuyoshi Takasaki; Koichi Sato; Hideki Ushirogochi; Itsuki Yamamura; Takeshi Isoda; Zhong Li; Youjun Yang; Toshio Kumagai
Serine and metallo b-lactamases catalyze the hydrolysis of blactam rings in all classes of blactam antibiotics which is a major cause of bacterial resistance to b-lactam antibiotics. Bacterial resistance is addressed clinically by combining a b-lactamase inhibitor, such as clavulanic acid, sulbactam, or tazobactam, with a b-lactam antibiotic (amoxicillin or piperacilin). Whereas this strategy is effective with the class A b-lactamase inhibitors, there is an urgent need to extend the spectrum of activity to the other classes of serine b-lactamases including the class C enzymes. Recently, new promising inhibitors of class C b-lactamases such as NXL104, AVE1330A, and diaroylphosphates have been disclosed. Reports from our laboratories on 6-methylidene penems as mechanism-based inhibitors of serine-reactive class A and C b-lactamases disclosed extensive structure–activity relationships with penems containing monocyclic, [6,5]-bicyclic,and [5,5,5]-tricyclic heterocycles that adopt the Z configuration at the C6 position. The mode of action of penem inhibitors involves acylation by the catalytic serine residues followed by b-lactam ring opening and a sequence of transformations amounting to a remarkable 7-endo trig rearrangement reaction. Penems 1–3 have been studied by a plethora of methods to establish the formation of the 1,4-dihydrothiazepine acyl–enzyme complex (Figure 1). The complex is stable to hydrolysis because of the displacement of water molecules. However, an issue concerns the absolute stereochemistry of the C7 moiety bearing the heterocyles. In dihydrothiazepine 4 bearing the methyltriazolyl heterocyle, the S-stereochemistry is evidenced by kinetic, computational, and X-ray crystallographic studies in class A and C enzymes. The dihydroimidazo ACHTUNGTRENNUNG[2,1-c]oxazine thiazepine 5 exists as the R-isomer in the crystal structure of both SHV-1 and GC1 enzymes. A novel hydrophobic p-p stacking interaction between the C7 heterocycle with Tyr105 in SHV-1 and Tyr224 in GC1 was revealed. Furthermore, calculated interaction energy differences between C7R and C7S isomers of eight 6-methylidene penems bearing [6,5]-fused bicyclic heterocycles favor the formation of the C7R over the C7S enantio-
Chemical Communications | 1996
Shigeki Sano; Hideki Ushirogochi; Kenji Morimoto; Satoshi Tamai; Yoshimitsu Nagao
The chiral mono-thiol diester, 1 or 2, is converted to the corresponding enantiomeric cyclised products,(–)-7 and (+)-7 or (–)-9, and (+)-9, depending on whether LDA or AlCl3–Et3N is used.
ChemMedChem | 2008
Aranapakam Mudumbai Venkatesan; Atul Agarwal; Takao Abe; Hideki Ushirogochi; Tsuyoshi Takasaki; Ado Mihira; Tarek S. Mansour
Recently, we reported on the discovery and biological activities of tricyclic 6-methylidene penems as mechanism-based inhibitors of serine b-lactamases. In combination with piperacilin, these inhibitors proved to be highly potent in inhibiting the hydrolysis of b-lactam rings, which is a major cause of bacterial resistance to b-lactam antibiotics. Earlier efforts focused on [5,5,5]-tricyclic penems, such as compound 1, which rearranges
Journal of Medicinal Chemistry | 2006
Aranapakam Mudumbai Venkatesan; Atul Agarwal; Takao Abe; Hideki Ushirogochi; Itsuka Yamamura; Mihira Ado; Takasaki Tsuyoshi; Osvaldo Dos Santos; Yansong Gu; Fuk-Wah Sum; Zhong Li; Gerry Francisco; Yang-I Lin; Peter J. Petersen; Youjun Yang; Toshio Kumagai; William J. Weiss; David M. Shlaes; James R. Knox; Tarek S. Mansour
Bioorganic & Medicinal Chemistry | 2008
Aranapakam Mudumbai Venkatesan; Atul Agarwal; Takao Abe; Hideki Ushirogochi; Mihira Ado; Takasaki Tsuyoshi; Osvaldo Dos Santos; Zhong Li; Gerry Francisco; Yang I. Lin; Peter J. Petersen; Youjun Yang; William J. Weiss; David M. Shlaes; Tarek S. Mansour
Archive | 2003
Takao Abe; Hiroshi Matsunaga; Ado Mihira; Chisato Sato; Hideki Ushirogochi; Koichi Sato; Tsuyoshi Takasaki; Aranapakam Mudumbai Venkatesan; Tarek S. Mansour
Journal of Organic Chemistry | 2004
Takao Abe; Chisato Sato; Hideki Ushirogochi; Koichi Sato; Tsuyoshi Takasaki; Takeshi Isoda; Ado Mihira; Itsuki Yamamura; Kazuhiko Hayashi; Toshio Kumagai; Satoshi Tamai; Motoo Shiro; and Aranapakam M. Venkatesan; Tarek S. Mansour